Patents by Inventor Stephan SCHLICKEISER

Stephan SCHLICKEISER has filed for patents to protect the following inventions. This listing includes patent applications that are pending as well as patents that have already been granted by the United States Patent and Trademark Office (USPTO).

  • A CXCR3+ CELL OR CELL PREPARATION FOR USE IN CANCER TREATMENT
    Publication number: 20240066061
    Abstract: The invention provides a modified T cell, or an isolated population of immune cells expressing a CXCR3 isoform selected from CXCR3A, CXCR3B, and CXCR3alt, and optionally, further expressing transgenes comprising an artificial T cell receptor, and/or a CXCR3 ligand, for use as a medicament. The invention also provides the methods to obtain said cells, or populations of cells from a plurality of immune cells derived from a human subject. The invention also relates to assessment of CXCR3 splice variants and its ligands CXCL9, CXCL10, and CXCL11 in muscle-invasive bladder cancer (MIBC) patients, to enable patients to be stratified for their predicted response to a chemotherapy drug treatment, or clinical outcome.
    Type: Application
    Filed: January 12, 2022
    Publication date: February 29, 2024
    Applicant: CHARITÉ-UNIVERSITÄTSMEDIZIN BERLIN
    Inventors: Hans Dieter VOLK, Michael SCHMÜCK-HENNERESSE, Tino VOLLMER, Petra REINKE, Stephan SCHLICKEISER